跳至主要内容
临床试验/IRCT20100228003449N31
IRCT20100228003449N31招募中2 期

Comparing efficacy and safety of different doses of dexamethasone in hospitalized patients with COVID-19

Tehran University of Medical Sciences0 个研究点目标入组 119 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
入组人数
119

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 85 years(—)
性别
All

入选标准

  • Adult patients (18-85 years old)
  • With diagnose of COVID-19 according to laboratory, clinical or radiological findings
  • With indication for hospitalization

排除标准

  • Contraindication of corticosteroids (uncontrolled diabetes mellitus, active bacteria, fungal or parasite infections, hypersensitivity reactions, close angle glaucoma, uncontrolled neuropsychiatric disorders, unstable cardiovascular disorders including acute myocardial infarction, acute thrombosis, uncontrolled hypertension, viral hepatitis, history of corticosteroids induced myopathy)
  • History of recent corticosteroids or other immunosuppressant drugs use

研究者

相似试验